Clinical Trials Browser

Phase 1 × Central Nervous System Neoplasms × Magnetic Resonance Spectroscopy × Clear all

NCT04732065 2026-03-17

PNOC023

Phase 1 Recruiting

Ependymoma, Glioblastoma, Central Nervous System Neoplasms

NCT05720624 2025-10-22

Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation

Phase 1 Withdrawn

Central Nervous System Neoplasms

NCT03598244 2025-04-20

Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

Phase 1 Active not recruiting

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma, Central Nervous System Neoplasms

NCT03565367 2023-12-21

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors

Phase 1 Completed

9 enrolled 6 charts

Central Nervous System Neoplasms

NCT00633958 2021-10-20

FLT

Phase 1 Terminated

Disease, Central Nervous System Neoplasms

NCT00003410 2013-06-26

Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas

Phase 1 Completed

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma